Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RODI
2176
DELISTED
iPath Return on Disability ETN
RODI
| $2M | ﹤0.01% |
16,500
| – | – |
|
2177
Rocket Pharmaceuticals
RCKT
$394M
| $2M | ﹤0.01% |
45,180
+4,533
| +11% | +$197K |
|
2178
Gabelli Equity Trust
GAB
$1.79B
| $2M | ﹤0.01% |
299,760
+270,171
| +913% | +$1.89M |
|
2179
PagerDuty
PD
$902M
| $2M | ﹤0.01% |
46,896
+36,488
| +351% | +$1.48M |
|
2180
Freshpet
FRPT
$3.22B
| $2M | ﹤0.01% |
12,249
-26,904
| -69% | -$4.59M |
|
|
AEL
2181
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.99M | ﹤0.01% |
61,599
-67,330
| -52% | -$2.13M |
|
2182
Performance Food Group
PFGC
$18B
| $1.99M | ﹤0.01% |
40,989
-98,768
| -71% | -$5.22M |
|
2183
Trinity Industries
TRN
$2.38B
| $1.98M | ﹤0.01% |
73,770
-24,763
| -25% | -$698K |
|
|
FLOW
2184
DELISTED
SPX FLOW, Inc.
FLOW
| $1.98M | ﹤0.01% |
30,418
-23,102
| -43% | -$1.54M |
|
|
KRTX
2185
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.98M | ﹤0.01% |
17,373
-12,930
| -43% | -$1.51M |
|
2186
ePlus
PLUS
$2.34B
| $1.98M | ﹤0.01% |
45,638
-18,592
| -29% | -$888K |
|
2187
NETSCOUT
NTCT
$2.79B
| $1.98M | ﹤0.01% |
69,273
+6,634
| +11% | +$188K |
|
2188
CALL
Duke Energy
DUK
$97.3B
| $1.97M | ﹤0.01% |
20,000
| – | – |
|
|
ADAM
2189
Adamas Trust
ADAM
$883M
| $1.97M | ﹤0.01% |
110,335
-49,669
| -31% | -$903K |
|
|
ERF
2190
DELISTED
Enerplus Corporation
ERF
| $1.97M | ﹤0.01% |
274,036
-144,527
| -35% | -$892K |
|
|
PDM
2191
Piedmont Realty Trust
PDM
$1.19B
| $1.97M | ﹤0.01% |
106,585
-171,323
| -62% | -$3.19M |
|
2192
Diodes
DIOD
$4.84B
| $1.96M | ﹤0.01% |
24,609
-29,047
| -54% | -$2.23M |
|
2193
Avista
AVA
$3.24B
| $1.96M | ﹤0.01% |
45,896
-86,184
| -65% | -$3.95M |
|
2194
Designer Brands
DBI
$333M
| $1.95M | ﹤0.01% |
117,933
+40,946
| +53% | +$721K |
|
2195
Minerals Technologies
MTX
$2.34B
| $1.95M | ﹤0.01% |
24,833
-7,204
| -22% | -$582K |
|
2196
iShares MSCI Sweden ETF
EWD
$595M
| $1.95M | ﹤0.01% |
+42,039
| New | +$2M |
|
2197
Global X FinTech ETF
FINX
$170M
| $1.95M | ﹤0.01% |
40,866
+23,204
| +131% | +$1.07M |
|
2198
Park National Corp
PRK
$3.67B
| $1.95M | ﹤0.01% |
16,573
-5,787
| -26% | -$728K |
|
2199
Andersons Inc
ANDE
$2.22B
| $1.94M | ﹤0.01% |
63,653
+22,621
| +55% | +$682K |
|
2200
Atkore
ATKR
$3.16B
| $1.94M | ﹤0.01% |
27,338
-26,685
| -49% | -$2.03M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.